Brain cancer research is going to focus tremendously on glioblastoma and for all of the right reasons. It is one of the most important names to consider when it comes to this particular field, which is something that you can figure out in due time. Seeing as how treatment may be troublesome to find, though, what if I were to tell you that a tandem of drugs can bring about certain degrees of success? I believe that it is a point to take into consideration when considering such a serious ailment.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
No matter where the results of the study go, I do not think that anyone can argue with the fact that possibilities are going to be focused on in great detail. Brain cancer research is all about finding out what is going to work best in the long term, which is something that should go without saying. Sometimes, though, researchers have to be able to find more unique combinations that have potential healing properties. This story, in my opinion, is one that can bring even greater results about in due time.
US News and World Report posted an article about a potential treatment that could prove useful for the sake of treating glioblastoma. This is one point that should be looked into but you have to keep in mind that this condition stands as one of the most aggressive and common conditions seen in the brain. According to a study that was done by the University of Zurich, it is "virtually incurable." That being said, it seems like a two-pronged drug therapy approach could prove useful in the long term.
The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?
To me, this is one of the best cases that can be taken into account and I do not think that anyone in the realm of brain cancer research can overlook this. This is especially true when you take into consideration that the T cells, thanks to the incorporation of another drug, can be halted in terms of regulation. The way that this could prove beneficial is through the survival rate boosting from 25% to 80%. It's a great point to consider, which is especially true for organizations along the lines of V-A-B-C.
No matter where the results of the study go, I do not think that anyone can argue with the fact that possibilities are going to be focused on in great detail. Brain cancer research is all about finding out what is going to work best in the long term, which is something that should go without saying. Sometimes, though, researchers have to be able to find more unique combinations that have potential healing properties. This story, in my opinion, is one that can bring even greater results about in due time.
About the Author:
Contact Voices Against Brain Cancer if you are seeking some more information about brain cancer awareness and research.
